世界の大うつ病性障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Major Depressive Disorder Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3530 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、大うつ病性障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、生物学的療法、瞑想、理学療法、その他）、用途別市場規模（25歳以下、25〜45歳、45歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・大うつ病性障害治療の市場動向 ・企業の競争状況、市場シェア ・大うつ病性障害治療の種類別市場規模（薬物療法、生物学的療法、瞑想、理学療法、その他） ・大うつ病性障害治療の用途別市場規模（25歳以下、25〜45歳、45歳以上） ・大うつ病性障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・大うつ病性障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・大うつ病性障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・大うつ病性障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・大うつ病性障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eli Lilly、H. Lundbeck、Otsuka Pharmaceutical、AstraZeneca、Alkermes、Takeda Pharmaceutical、Naurex、Euthymics Bioscience、E-therapeutics） ・結論

Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.
In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.

Market Analysis and Insights: Global Major Depressive Disorder Therapeutic Market
The global Major Depressive Disorder Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Major Depressive Disorder Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Major Depressive Disorder Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Major Depressive Disorder Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Major Depressive Disorder Therapeutic market.

Global Major Depressive Disorder Therapeutic Scope and Market Size
Major Depressive Disorder Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Major Depressive Disorder Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs Therapy
Biological Therapy
Meditation
Physiotherapy
Other

Segment by Application
Under 25 Years Old
25-45 Years Old
Above 45 Years Old

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Eli Lilly
H. Lundbeck
Otsuka Pharmaceutical
AstraZeneca
Alkermes
Takeda Pharmaceutical
Naurex
Euthymics Bioscience

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Major Depressive Disorder Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs Therapy
1.2.3 Biological Therapy
1.2.4 Meditation
1.2.5 Physiotherapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Major Depressive Disorder Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Under 25 Years Old
1.3.3 25-45 Years Old
1.3.4 Above 45 Years Old
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Major Depressive Disorder Therapeutic Market Perspective (2016-2027)
2.2 Major Depressive Disorder Therapeutic Growth Trends by Regions
2.2.1 Major Depressive Disorder Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Major Depressive Disorder Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Major Depressive Disorder Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Major Depressive Disorder Therapeutic Industry Dynamic
2.3.1 Major Depressive Disorder Therapeutic Market Trends
2.3.2 Major Depressive Disorder Therapeutic Market Drivers
2.3.3 Major Depressive Disorder Therapeutic Market Challenges
2.3.4 Major Depressive Disorder Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Major Depressive Disorder Therapeutic Players by Revenue
3.1.1 Global Top Major Depressive Disorder Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Major Depressive Disorder Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Major Depressive Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Major Depressive Disorder Therapeutic Revenue
3.4 Global Major Depressive Disorder Therapeutic Market Concentration Ratio
3.4.1 Global Major Depressive Disorder Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder Therapeutic Revenue in 2020
3.5 Major Depressive Disorder Therapeutic Key Players Head office and Area Served
3.6 Key Players Major Depressive Disorder Therapeutic Product Solution and Service
3.7 Date of Enter into Major Depressive Disorder Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Major Depressive Disorder Therapeutic Breakdown Data by Type
4.1 Global Major Depressive Disorder Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Major Depressive Disorder Therapeutic Forecasted Market Size by Type (2022-2027)

5 Major Depressive Disorder Therapeutic Breakdown Data by Application
5.1 Global Major Depressive Disorder Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Major Depressive Disorder Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Major Depressive Disorder Therapeutic Market Size (2016-2027)
6.2 North America Major Depressive Disorder Therapeutic Market Size by Type
6.2.1 North America Major Depressive Disorder Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Major Depressive Disorder Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Major Depressive Disorder Therapeutic Market Size by Type (2016-2027)
6.3 North America Major Depressive Disorder Therapeutic Market Size by Application
6.3.1 North America Major Depressive Disorder Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Major Depressive Disorder Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Major Depressive Disorder Therapeutic Market Size by Application (2016-2027)
6.4 North America Major Depressive Disorder Therapeutic Market Size by Country
6.4.1 North America Major Depressive Disorder Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Major Depressive Disorder Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Major Depressive Disorder Therapeutic Market Size (2016-2027)
7.2 Europe Major Depressive Disorder Therapeutic Market Size by Type
7.2.1 Europe Major Depressive Disorder Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Major Depressive Disorder Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Major Depressive Disorder Therapeutic Market Size by Type (2016-2027)
7.3 Europe Major Depressive Disorder Therapeutic Market Size by Application
7.3.1 Europe Major Depressive Disorder Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Major Depressive Disorder Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Major Depressive Disorder Therapeutic Market Size by Application (2016-2027)
7.4 Europe Major Depressive Disorder Therapeutic Market Size by Country
7.4.1 Europe Major Depressive Disorder Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Major Depressive Disorder Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Major Depressive Disorder Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Type
8.2.1 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Application
8.3.1 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Region
8.4.1 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Major Depressive Disorder Therapeutic Market Size (2016-2027)
9.2 Latin America Major Depressive Disorder Therapeutic Market Size by Type
9.2.1 Latin America Major Depressive Disorder Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Major Depressive Disorder Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Major Depressive Disorder Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Major Depressive Disorder Therapeutic Market Size by Application
9.3.1 Latin America Major Depressive Disorder Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Major Depressive Disorder Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Major Depressive Disorder Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Major Depressive Disorder Therapeutic Market Size by Country
9.4.1 Latin America Major Depressive Disorder Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Major Depressive Disorder Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Major Depressive Disorder Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Type
10.2.1 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Application
10.3.1 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Country
10.4.1 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Major Depressive Disorder Therapeutic Introduction
11.1.4 Pfizer Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Major Depressive Disorder Therapeutic Introduction
11.2.4 Eli Lilly Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 H. Lundbeck
11.3.1 H. Lundbeck Company Details
11.3.2 H. Lundbeck Business Overview
11.3.3 H. Lundbeck Major Depressive Disorder Therapeutic Introduction
11.3.4 H. Lundbeck Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.3.5 H. Lundbeck Recent Development
11.4 Otsuka Pharmaceutical
11.4.1 Otsuka Pharmaceutical Company Details
11.4.2 Otsuka Pharmaceutical Business Overview
11.4.3 Otsuka Pharmaceutical Major Depressive Disorder Therapeutic Introduction
11.4.4 Otsuka Pharmaceutical Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.4.5 Otsuka Pharmaceutical Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Major Depressive Disorder Therapeutic Introduction
11.5.4 AstraZeneca Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Alkermes
11.6.1 Alkermes Company Details
11.6.2 Alkermes Business Overview
11.6.3 Alkermes Major Depressive Disorder Therapeutic Introduction
11.6.4 Alkermes Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.6.5 Alkermes Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Major Depressive Disorder Therapeutic Introduction
11.7.4 Takeda Pharmaceutical Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Naurex
11.8.1 Naurex Company Details
11.8.2 Naurex Business Overview
11.8.3 Naurex Major Depressive Disorder Therapeutic Introduction
11.8.4 Naurex Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.8.5 Naurex Recent Development
11.9 Euthymics Bioscience
11.9.1 Euthymics Bioscience Company Details
11.9.2 Euthymics Bioscience Business Overview
11.9.3 Euthymics Bioscience Major Depressive Disorder Therapeutic Introduction
11.9.4 Euthymics Bioscience Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.9.5 Euthymics Bioscience Recent Development
11.10 E-therapeutics
11.10.1 E-therapeutics Company Details
11.10.2 E-therapeutics Business Overview
11.10.3 E-therapeutics Major Depressive Disorder Therapeutic Introduction
11.10.4 E-therapeutics Revenue in Major Depressive Disorder Therapeutic Business (2016-2021)
11.10.5 E-therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Major Depressive Disorder Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs Therapy
Table 3. Key Players of Biological Therapy
Table 4. Key Players of Meditation
Table 5. Key Players of Physiotherapy
Table 6. Key Players of Other
Table 7. Global Major Depressive Disorder Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Major Depressive Disorder Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Major Depressive Disorder Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Major Depressive Disorder Therapeutic Market Share by Regions (2016-2021)
Table 11. Global Major Depressive Disorder Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Major Depressive Disorder Therapeutic Market Share by Regions (2022-2027)
Table 13. Major Depressive Disorder Therapeutic Market Trends
Table 14. Major Depressive Disorder Therapeutic Market Drivers
Table 15. Major Depressive Disorder Therapeutic Market Challenges
Table 16. Major Depressive Disorder Therapeutic Market Restraints
Table 17. Global Major Depressive Disorder Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Major Depressive Disorder Therapeutic Market Share by Players (2016-2021)
Table 19. Global Top Major Depressive Disorder Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder Therapeutic as of 2020)
Table 20. Ranking of Global Top Major Depressive Disorder Therapeutic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Major Depressive Disorder Therapeutic Product Solution and Service
Table 24. Date of Enter into Major Depressive Disorder Therapeutic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Major Depressive Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Major Depressive Disorder Therapeutic Revenue Market Share by Type (2016-2021)
Table 28. Global Major Depressive Disorder Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Major Depressive Disorder Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Major Depressive Disorder Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Major Depressive Disorder Therapeutic Revenue Market Share by Application (2016-2021)
Table 32. Global Major Depressive Disorder Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Major Depressive Disorder Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Major Depressive Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Major Depressive Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Major Depressive Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Major Depressive Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Major Depressive Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Major Depressive Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Major Depressive Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Major Depressive Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Major Depressive Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Major Depressive Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Major Depressive Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Major Depressive Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Major Depressive Disorder Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Major Depressive Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Major Depressive Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Major Depressive Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Major Depressive Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Major Depressive Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Major Depressive Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Major Depressive Disorder Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Major Depressive Disorder Therapeutic Product
Table 67. Pfizer Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Major Depressive Disorder Therapeutic Product
Table 72. Eli Lilly Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly Recent Development
Table 74. H. Lundbeck Company Details
Table 75. H. Lundbeck Business Overview
Table 76. H. Lundbeck Major Depressive Disorder Therapeutic Product
Table 77. H. Lundbeck Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 78. H. Lundbeck Recent Development
Table 79. Otsuka Pharmaceutical Company Details
Table 80. Otsuka Pharmaceutical Business Overview
Table 81. Otsuka Pharmaceutical Major Depressive Disorder Therapeutic Product
Table 82. Otsuka Pharmaceutical Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 83. Otsuka Pharmaceutical Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Major Depressive Disorder Therapeutic Product
Table 87. AstraZeneca Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Alkermes Company Details
Table 90. Alkermes Business Overview
Table 91. Alkermes Major Depressive Disorder Therapeutic Product
Table 92. Alkermes Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 93. Alkermes Recent Development
Table 94. Takeda Pharmaceutical Company Details
Table 95. Takeda Pharmaceutical Business Overview
Table 96. Takeda Pharmaceutical Major Depressive Disorder Therapeutic Product
Table 97. Takeda Pharmaceutical Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 98. Takeda Pharmaceutical Recent Development
Table 99. Naurex Company Details
Table 100. Naurex Business Overview
Table 101. Naurex Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 102. Naurex Recent Development
Table 103. Euthymics Bioscience Company Details
Table 104. Euthymics Bioscience Business Overview
Table 105. Euthymics Bioscience Major Depressive Disorder Therapeutic Product
Table 106. Euthymics Bioscience Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 107. Euthymics Bioscience Recent Development
Table 108. E-therapeutics Company Details
Table 109. E-therapeutics Business Overview
Table 110. E-therapeutics Major Depressive Disorder Therapeutic Product
Table 111. E-therapeutics Revenue in Major Depressive Disorder Therapeutic Business (2016-2021) & (US$ Million)
Table 112. E-therapeutics Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Major Depressive Disorder Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Drugs Therapy Features
Figure 3. Biological Therapy Features
Figure 4. Meditation Features
Figure 5. Physiotherapy Features
Figure 6. Other Features
Figure 7. Global Major Depressive Disorder Therapeutic Market Share by Application: 2020 VS 2027
Figure 8. Under 25 Years Old Case Studies
Figure 9. 25-45 Years Old Case Studies
Figure 10. Above 45 Years Old Case Studies
Figure 11. Major Depressive Disorder Therapeutic Report Years Considered
Figure 12. Global Major Depressive Disorder Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Major Depressive Disorder Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Major Depressive Disorder Therapeutic Market Share by Regions: 2020 VS 2027
Figure 15. Global Major Depressive Disorder Therapeutic Market Share by Regions (2022-2027)
Figure 16. Global Major Depressive Disorder Therapeutic Market Share by Players in 2020
Figure 17. Global Top Major Depressive Disorder Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder Therapeutic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Major Depressive Disorder Therapeutic Revenue in 2020
Figure 19. Global Major Depressive Disorder Therapeutic Revenue Market Share by Type (2016-2021)
Figure 20. Global Major Depressive Disorder Therapeutic Revenue Market Share by Type (2022-2027)
Figure 21. North America Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Major Depressive Disorder Therapeutic Market Share by Type (2016-2027)
Figure 23. North America Major Depressive Disorder Therapeutic Market Share by Application (2016-2027)
Figure 24. North America Major Depressive Disorder Therapeutic Market Share by Country (2016-2027)
Figure 25. United States Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Major Depressive Disorder Therapeutic Market Share by Type (2016-2027)
Figure 29. Europe Major Depressive Disorder Therapeutic Market Share by Application (2016-2027)
Figure 30. Europe Major Depressive Disorder Therapeutic Market Share by Country (2016-2027)
Figure 31. Germany Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Major Depressive Disorder Therapeutic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Major Depressive Disorder Therapeutic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Major Depressive Disorder Therapeutic Market Share by Region (2016-2027)
Figure 41. China Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Major Depressive Disorder Therapeutic Market Share by Type (2016-2027)
Figure 49. Latin America Major Depressive Disorder Therapeutic Market Share by Application (2016-2027)
Figure 50. Latin America Major Depressive Disorder Therapeutic Market Share by Country (2016-2027)
Figure 51. Mexico Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Major Depressive Disorder Therapeutic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Major Depressive Disorder Therapeutic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Major Depressive Disorder Therapeutic Market Share by Country (2016-2027)
Figure 57. Turkey Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Major Depressive Disorder Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 62. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 63. Otsuka Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 65. Alkermes Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 66. Takeda Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 67. Naurex Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 68. Euthymics Bioscience Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 69. E-therapeutics Revenue Growth Rate in Major Depressive Disorder Therapeutic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---